Marquette Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Marquette Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-25,760	Closed	-$59.8K	–	257
2024 Q2	$59.8K	Hold	25,760	–	–	0.01%	137
2024 Q1	$72.6K	Hold	25,760	–	–	0.01%	132
2023 Q4	$81.9K	Hold	25,760	–	–	0.02%	124
2023 Q3	$85K	Sell	25,760 -5,328	-17%	-$16.6K	0.02%	117
2023 Q2	$103K	Hold	31,088	–	–	0.03%	117
2023 Q1	$103K	Buy	31,088 +10,068	+48%	+$35.2K	0.03%	107
2022 Q4	$75.9K	Buy	21,020 +7,705	+58%	+$50.4K	0.02%	129
2022 Q3	$118K	Hold	13,315	–	–	0.04%	96
2022 Q2	$103K	Hold	13,315	–	–	0.03%	129
2022 Q1	$125K	Hold	13,315	–	–	0.03%	124
2021 Q4	$92K	Buy	13,315 +81	+0.6%	+$681	0.02%	157
2021 Q3	$126K	Buy	13,234 +4,315	+48%	+$40.5K	0.03%	129
2021 Q2	$89K	Buy	+8,919	New	+$99.3K	0.02%	142

Other funds holding LUMO

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

GWM

Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Marquette Asset Management's LUMO Position: Q3 2024 in Review

Marquette Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2024, closing a stake of 25,760 shares — an estimated $59.8K sold.

Marquette Asset Management first reported a position in LUMO in Q2 2021 and held it in 13 quarters. The position peaked at $126K in Q3 2021. 28 funds tracked by Wall St. Rank hold LUMO as of Q3 2024.

Marquette Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Marquette Asset Management sold 25,760 Lumos Pharma, Inc. Common Stock shares in Q3 2024, an estimated $59.8K.
Marquette Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
Marquette Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $126K in Q3 2021.
28 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2024.

Based on Marquette Asset Management's 13F filing for Q3 2024, filed 8 Oct 2024.